Stay updated with breaking news from Small Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.
TSX VENTURE COMPANIES Minto Metals Corp. BULLETIN TYPE: Delist BULLETIN DATE: 24, 2023 TSX Venture Tier 2 Company Further to TSX Venture Exchange bulletin dated 07, 2023, effective at the close of business on Tuesday, 31, 2023, the common shares... - Veroeffentlicht am 25.10.2023
TORONTO & LONDON, October 23, 2023--Cybin Inc. (NYSE American:CYBN) (NEO:CYBN) ("Cybin", or the "Company") and Small Pharma Inc. (TSXV:DMT) (OTCQB:DMTTF) ("Small Pharma") are pleased to announce the completion of the previously-announced acquisition by Cybin of Small Pharma by way of a plan of arrangement under the Business Corporations Act (British Columbia), and pursuant to the terms of an arrangement agreement dated August 28, 2023 between Cybin and Small Pharma (the "Arrangement"). As a resu
This news release constitutes a “designated news release” for the purposes of Cybin’s prospectus supplements each dated August 23, 2023, to its short form base shelf prospectus dated August 17,...
Psychedelics companies Cybin Inc. (NYSE: CYBN) and Small Pharma Inc. (OTCQB: DMTTF) have completed their August acquisition agreement.